Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer

  1. Twelves, C.
  2. Cortes, J.
  3. Vahdat, L.
  4. Wanders, J.
  5. Akerele, C.
  6. Kaufman, P.
Revista:
Clinical Breast Cancer

ISSN: 1526-8209

Ano de publicación: 2010

Volume: 10

Número: 2

Páxinas: 160-163

Tipo: Estudo Breve

DOI: 10.3816/CBC.2010.N.023 GOOGLE SCHOLAR
Fonte de datos: Scopus